LOS ANGELES (MarketWatch) � Coventry Health Care Inc. didn�t seem to feel the effects of a feared downturn in the managed-care sector Friday as the company�s shares jumped on a rosy earnings report.
Coventry CVH �was up nearly 11% to $34.07 after it reported higher revenue and earnings that beat Wall Street estimates, and projected full-year earnings would exceed analyst forecasts.
Click to Play Asia hardest hit by viral hepatitisNearly 70% of people infected with viral hepatitis live in Asia. The co-founders of Coalition to Eradicate Viral Hepatitis in Asia Pacific, Charles Gore and Joseph Sung, talk about ways to fight the disease.
The company said net income was $91.7 million, or 65 cents a share, compared with $224.5 million, or $1.50 a share, a year ago. Sales were $3.52 billion against last year�s $3.03 billion. Coventry�s adjusted earnings were 68 cents a share, while analysts polled by Thomson Reuters called for 63 cents a share.
The company says it now sees earnings of $3.10 to $3.30 a share. The Thomson Reuters estimate was for $2.71 a share.
Allen F. Wise, Coventry�s chairman and chief executive, said in a written statement that the company was seeing improvement in its Medicaid and Medicare programs, and was getting costs under control in its Kentucky operations, a trouble spot in the past.
Earlier in the week, WellPoint Inc. WLP �told analysts that it feared the troubles it had in the second quarter would spread to other health-care insurers, casting shares down. Those effects ended up being muted.
But shares of Molina Healthcare Inc. MOH � did feel some of those effects early on in the trading day when shares fell more than 9% at one point. A broad market rally, however, helped Molina recover somewhat and the company�s shares ended the day down 1% to $24.99
The Medicaid insurer reported an 80-cent loss for the second quarter, and withdrew its forecast for the rest of the fiscal year. That stood in sharp contrast to the 2-cent gain that Thomson Reuters analysts sought from the company, as higher costs in Molina�s Texas operations took a bite out of earnings, as well as bigger medical expense ratios in some of its other regions.
/quotes/zigman/317140/quotes/nls/moh MOH 24.99, -0.30, -1.19% Molina Healthcare
Long Beach, Calif.-based Molina�s 80-cent loss translated to a shortfall of $37.3 million, swinging from a gain of $17.4 million, or 38 cents a share, for the same period a year ago. Revenue for the period was $1.54 billion against last year�s $1.17 billion.
Molina saw a rapid membership expansion in Texas, adding 172,000 members and more than a quarter-billion dollars in sales. But costs also were driven up and the medical-loss ratio � the percentage of revenue spent on providing care � was 109.4%, up from 95% a year ago. Texas accounts for nearly a quarter of Molina�s premiums.
In the Hidalgo and El Paso areas, the medical-loss ratios were 139% and 146%. But the company said the state�s payout rates should improve, while costs will be driven down, and it expects to return to profitability in the region in the next several months.
Click to Play U.S. week ahead: Fed, sales reportsInvestors are likely to turn from a focus on earnings to the Federal Reserve's next rate meeting, July auto and retail sales and the July labor report. Photo: Bloomberg.
Analyst Matthew Borsch of Goldman Sachs said in a note to clients that the Texas episode is proving to be a �learning experience� for the company that was expected to reap rewards from the Supreme Court�s upholding of President Barack Obama�s health-care overhaul. The bill includes Medicaid expansion that should benefit Molina.
�While the [second-quarter] loss is a big disappointment, this year should prove to be a learning experience for [Molina] and the industry as states move to convert the high morbidity segments of the Medicaid population to private-sector managed care,� Borsch wrote. �The opportunity is big since these members represent a minority of members but a majority of spending. However, the [second-quarter] loss underlines the importance of adequate contract terms and rates.�
No comments:
Post a Comment